EMAIL THIS PAGE TO A FRIEND

FEBS letters

Methyllycaconitine: a selective probe for neuronal alpha-bungarotoxin binding sites.


PMID 2226787

Abstract

The ability of methyllycaconitine (MLA) to inhibit the binding of [125I]alpha-bungarotoxin to rat brain membranes, frog and human muscle extracts and the human muscle cell line TE671 has been measured. MLA showed a markedly higher affinity for the rat brain site (Ki 1.4 x 10(-9) M) than for the muscle receptors (Ki 10(-5)-10(-6) M). Structure modelling techniques were used to fit the structure of MLA to a nicotinic pharmacophore model. MLA is the first low molecular weight ligand to be shown to discriminate between muscle nicotinic receptors and their alpha-bungarotoxin-binding counterpart in the brain, and as such may be a useful structural probe for pursuing the structural and functional properties of the neuronal protein.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

M168
Methyllycaconitine citrate salt, from Delphinium brownii seeds, ≥96% (HPLC)
C37H50N2O10 · xC6H8O7